Health Catalyst, Inc. (ticker: HCAT), a software solution provider based in Salt Lake City, Utah, recently announced a significant leadership change. On February 18, 2026, the company appointed Ben Albert as its new Chief Executive Officer. This leadership transition comes at a time when the company’s stock is experiencing notable volatility. On February 17, 2026, Health Catalyst’s stock closed at $1.67, marking its 52-week low. The following day, the stock closed at $1.73, remaining close to this low point.
Over the past year, Health Catalyst’s share price has demonstrated significant fluctuations. The stock reached its 52-week high of $5.06 on May 7, 2025, indicating a period of heightened investor interest. However, the subsequent decline to its current levels underscores the challenges the company faces in stabilizing its market position.
Financially, Health Catalyst is characterized by a negative earnings profile. The company’s price-to-earnings (P/E) ratio stands at -1.07, reflecting ongoing losses. Additionally, the price-to-book (P/B) ratio is 0.381, suggesting that the company trades at a discount to its book value. These valuation multiples highlight a market perception that does not yet align with earnings expectations, contributing to the stock’s volatility.
With a market capitalization of $120.24 million, Health Catalyst continues to serve primarily within the state of Utah, focusing on delivering healthcare software solutions for hospitals. These solutions aim to efficiently manage operational, financial, clinical, and research data. Despite the current financial challenges, the company remains committed to its mission of enhancing healthcare management through innovative software solutions.
Investors and stakeholders can find more information about Health Catalyst’s products and services on their website, www.healthcatalyst.com . The company’s stock is traded on the Nasdaq, providing an avenue for investment in its future growth and development.
